disease

(redirected from Metabolic Bone Disease)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Metabolic Bone Disease: osteoporosis
References in periodicals archive ?
Biochemical studies are routinely used in the identification of metabolic bone disease and whilst hypocalcaemia and hypophosphatemia can be characteristic of osteomalacia, an increase in the levels of serum alkaline phosphatase (ALP) is the most common biochemical sign.
Metabolic bone disease in juvenile Humboldt penguins (Spheniscus humboldti): investigation of ionized calcium, parathyroid hormone, and vitamin [D.
AIM: To estimate the prevalence and identify the risk factors for metabolic bone disease in patients with cirrhosis.
Metabolic bone disease was present in 45 per cent of patients with low levels of serum 25 (OH) vitamin D (7).
I especially liked the chapter on the thyroid gland for its concise presentation of the essentials of this high-volume branch of endocrine testing, the chapter on metabolic bone disease for its timeliness and its clear treatment of the relatively complex assortment of biochemical markers available in this area, and the chapter on endocrine malignancies for its up-to-date review of the literature on the subject.
They provide students and physicians with descriptions and illustrations of upper limb, lower limb, and spine anatomy, trauma, and degenerative and acquired disorders, and the basic science of the musculoskeletal system, metabolic bone disease, rheumatologic diseases, tumors, the sequelae of trauma, and congenital deformities.
Speakers highlighted overview of Thalessemia, Management of Thalessemia with emphasis on Hb-F Augmentation and BMT, Treatment of Complications/Iron Chelation Therapy, Metabolic Bone Disease in Thalessemia, Bone Marrow Transplant - Experience in AFBMT, Splenectomy in Patients of Thalessemia and Prevention of Thalessemia.
It had suffered metabolic bone disease due to a deficiency of calcium and Vitamin D3, vet Hannah Bould told the court.
6 /PRNewswire-USNewswire/ -- Forty-three percent of patients scheduled to undergo orthopaedic surgery have insufficient levels of vitamin D and two out of five of those patients had levels low enough to place them at risk for metabolic bone disease, according to a study published this month in the October 6th issue of the Journal of Bone and Joint Surgery (JBJS).
Metabolic bone disease remains a significant and common complication of CD.
For patients with stage 5 CKD who have low bone mineral density or fragility fractures, a double tetracycline-labeled bone biopsy is necessary to rule out other causes of metabolic bone disease and confirm a diagnosis of osteoporosis.
When noninvasive measurements of bone mineral density (BMD) became available, the most common metabolic bone disease, osteoporosis, began to receive attention from researchers, pharmaceutical companies, and clinical practitioners.